EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

A Randomized Waitlist‐Controlled Trial of a Positive Psychology Intervention for Irritable Bowel Syndrome: The WISH Proof‐of‐Concept Trial

Elizabeth N Madva, Jeff C Huffman, Crystal Castillo, Lauren E Harnedy, Tesiya Franklin, M Tim Song, Helen Burton-Murray iD, Brian Healy, Kyle Staller iD, Stephen Bartels, Braden Kuo, Laurie Keefer und 1 weitere

Neurogastroenterology & Motility · 2025-11 · 37 (11)

DOI: 10.1111/nmo.70146 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 24.08.2025. Verfasst von Elizabeth N Madva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Psychology, Positive, Behavior Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, Harvard Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Though greater positive psychological well‐being (PPWB) is associated with both improved physical and mental health in irritable bowel syndrome (IBS), it has not yet been explored as a primary target of brain–gut behavior therapies (BGBTs). Accordingly, we developed a novel, 9‐week, phone‐delivered BGBT to cultivate PPWB in IBS, and examined its feasibility, acceptability, and preliminary effects in a randomized waitlist‐controlled proof‐of‐concept trial.

Methods

Twenty‐two adults with IBS meeting Rome IV criteria were randomized, stratified by gender and IBS subtype, to the intervention ( n = 12) or waitlist‐control (WLC; n = 10) groups. Participants completed specific positive psychology (PP) activities and phone sessions weekly with an interventionist. Intervention feasibility was assessed by the proportion of completed sessions, and acceptability by weekly ease/utility ratings. Exploratory psychological and health‐related self‐report measures were collected pre‐ and post‐intervention. Key Results Participants ( N = 22; ages 19–79; 55% female) completed 85% of sessions, above our a priori feasibility threshold of 65%. The intervention was rated as easy to complete (mean = 7.2/10, 95% CI: [6.70, 7.75]) and subjectively helpful (mean = 7.6/10, 95% CI: [7.14, 8.01]). Of the 18 participants who completed the intervention, 11 (61%) no longer met criteria for IBS post‐intervention. Compared to the WLC, the intervention led to promising but nonsignificant improvements in exploratory clinical outcomes including IBS symptom severity, IBS health‐related quality of life, and resilience, with effect sizes ranging from 0.1 to 0.7. Conclusions and Inferences This 9‐week, phone‐delivered intervention targeting greater PPWB in IBS was feasible, well‐accepted, and associated with promising improvements in key IBS‐related outcomes, highlighting the need for further testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromePsychology, PositiveBehavior TherapyHumansFemaleMaleAdultMiddle AgedProof of Concept StudyTreatment OutcomeFeasibility StudiesWaiting Lists

Stichwörter der Autor:innen

functional gastrointestinal disordersirritable bowel syndromepositive psychologypsychological resiliencepsychosomatic medicine

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Center for Neurointestinal Health, Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • The Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, New York, USA.

ORCID-Profile: Helen Burton-Murray, Kyle Staller

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • Harvard Medical School
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Madva, E. N., Huffman, J. C., Castillo, C., Harnedy, L. E., Franklin, T., Song, M. T., Burton-Murray, H., Healy, B., Staller, K., Bartels, S., Kuo, B., Keefer, L., & Celano, C. M. (2025). A Randomized Waitlist‐Controlled Trial of a Positive Psychology Intervention for Irritable Bowel Syndrome: The WISH Proof‐of‐Concept Trial. Neurogastroenterology & Motility, 37(11). https://doi.org/10.1111/nmo.70146

Vancouver

Madva EN, Huffman JC, Castillo C, Harnedy LE, Franklin T, Song MT, et al. A Randomized Waitlist‐Controlled Trial of a Positive Psychology Intervention for Irritable Bowel Syndrome: The WISH Proof‐of‐Concept Trial. Neurogastroenterology & Motility. 2025;37(11). doi:10.1111/nmo.70146

BibTeX
@article{Madva2025,
  author = {Madva, Elizabeth N and Huffman, Jeff C and Castillo, Crystal and Harnedy, Lauren E and Franklin, Tesiya and Song, M Tim and Burton-Murray, Helen and Healy, Brian and Staller, Kyle and Bartels, Stephen and Kuo, Braden and Keefer, Laurie and Celano, Christopher M},
  title = {A Randomized Waitlist‐Controlled Trial of a Positive Psychology Intervention for Irritable Bowel Syndrome: The WISH Proof‐of‐Concept Trial},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  volume = {37},
  number = {11},
  doi = {10.1111/nmo.70146}
}
Kostenlos starten →